Biocom California poised to bridge Korean biotech firms to US opportunities
[JPM 2025] Lotte Biologics to provide one-stop ADC services at Syracuse Campus
[JPM 2025] Chaebol scions in search of next growth drivers at JPM conference
Samsung Biologics powers up ADC business with new facility, key partnerships
Hanmi Pharmaceutical steps up in global obesity drug race
[JPM 2025] Samsung Biologics broadens biopharma horizons with new modality of investments
[JPM 2025] Celltrion highlights breakthrough therapies, unveils ambitious clinical plans by 2028
Samsung Biologics secures largest-ever deal with European pharma giant
Korean biotech leaders to take center stage at JP Morgan Healthcare Conference
LG Chem expands into Thai beauty market with new skin booster
MORE
![[JPM 2025] Lotte Biologics to provide one-stop ADC services at Syracuse Campus](https://wimg.heraldcorp.com/news/cms/2025/01/17/news-p.v1.20250117.adb1ba504b72499cac9093c004b52ea8_T1.jpg?type=h&h=320)
![[JPM 2025] Chaebol scions in search of next growth drivers at JPM conference](https://wimg.heraldcorp.com/news/cms/2025/01/19/news-p.v1.20250117.771b5e7788424cddbb43127e1ff269a8_T1.jpg?type=h&h=320)
![[JPM 2025] Samsung Biologics broadens biopharma horizons with new modality of investments](https://wimg.heraldcorp.com/news/cms/2025/01/15/news-p.v1.20250115.a284d560bed54f04994ef6394f0a8a57_T1.jpg?type=h&h=320)
![[JPM 2025] Celltrion highlights breakthrough therapies, unveils ambitious clinical plans by 2028](https://wimg.heraldcorp.com/news/cms/2025/01/15/news-p.v1.20250115.dd7c5d189cfb4630911294e08b28c869_T1.jpg?type=h&h=320)
